MedTrace Logo

Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 2

NCT03306836 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 408

Last updated 2017-10-11

No results posted yet for this study

Summary

In the stage of randomized controlled study, our purpose is to obtain the Intraoperative anticoagulation program supported by evidence-based medicine.

Conditions

  • Cerebral Aneurysm
  • Arteriovenous Malformations

Interventions

DRUG

Heparin Sodium

Infused with 5000 IU of Heparin Sodium

DRUG

Heparin Sodium

Infusion Heparin Sodium at a rate of 18 IU / kg.h

Sponsors & Collaborators

  • Tang-Du Hospital

    collaborator OTHER

  • Kunming Medical University

    collaborator OTHER

  • First Affiliated Hospital of Fujian Medical University

    collaborator OTHER

  • Nanjing PLA General Hospital

    collaborator OTHER

  • Fujian Medical University Union Hospital

    collaborator OTHER

  • Beijing Tiantan Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2020-09-30
Completion
2021-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03306836 on ClinicalTrials.gov